Author:
Calleja-Hernández Miguel Ángel,Guerrero-Peral Ángel Luis,Irimia-Sieira Pablo,Martínez-López Icíar,Santos-Lasaosa Sonia,Sarobe-Carricas Maite,López-Matencio José María Serra,Láinez-Andrés José Miguel
Reference25 articles.
1. Benemei S, Dussor G, TRP channels and migraine: recent developments and new therapeutic opportunities, Pharmaceuticals (Basel), 2019;12(2):54. doi: https://doi.org/10.3390/ph12020054.
2. Andreou AP, Edvinsson L, Mechanisms of migraine as a chronic evolutive condition, J Headache Pain, 2019;20(1):117. doi: https://doi.org/10.1186/s10194-019-1066-0.
3. How to integrate monoclonal antibodies targeting the calcitonin gene-related peptide or its receptor in daily clinical practice;Tiseo;J Headache Pain,2019
4. Nuevos medicamentos biológicos en la profilaxis de la migraña, Butlletí de Farmacovigilància de Catanlunya [revista en Internet], 2022;20(2). [consultado 16 Mar 2023]. marzo-abril. [aprox. 7 p.]. Disponible en: https://scientiasalut.gencat.cat/bitstream/handle/11351/7563/BFV_2022_20_02_cas.pdf?sequence=2&isAllowed=y.
5. CGRP en migraña: de la fisiopatología a la terapéutica;Santos-Lasaosa;Neurol Int,2022
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献